340B Pharm Compliance Analyst

Cooper University Hospital•Camden, NJ

1d•$29 - $48

About The Position

At Cooper University Health Care, our commitment to providing extraordinary health care begins with our team. Our extraordinary professionals are continuously discovering clinical innovations and enhanced access to the most up-to-date facilities, equipment, technologies and research protocols. We have a commitment to our employees to provide competitive rates and compensation programs. Cooper offers full and part-time employees a comprehensive benefits program, including health, dental, vision, life, disability, and retirement. We also provide attractive working conditions and opportunities for career growth through professional development. Discover why Cooper University Health Care is the employer of choice in South Jersey.

Requirements

At least 3 years previous experience in health care setting with exposure to pharmaceutical care and data analytics
Experience with Microsoft Excel
Excellent verbal and written communication skills
High School Diploma Required
Must obtain CPhT within 1year
Must obtain NJ Board of Pharmacy registration within 6 months

Nice To Haves

Pharmacy tech experience preferred
Knowledge of 340B software
Knowledge of state and federal medical assistance/health services programs, medical insurance & billing requirements preferred
Understanding of 340B acquisitioning and billing preferred
Strong knowledge of medical terminology and pharmaceutical nomenclature/calculations
Bachelor’s degree in Business/accounting preferred

Responsibilities

Assist with ensuring all 340B eligible sites are compliant including policy & procedure development
Provide education on 340B to staff and providers
Complete regular self audits and monitoring for compliance validation
Ensure patient, location & provider eligibility
Recommend program enhancements and cost saving opportunities
Provide collaboration with 340B Governance Committee
Participate in 340B Health organization educational sessions to ensure Cooper EIP has the current program and regulatory information to continue successfully.